[1]
Muhammad Amir Abbas, Muhammad Zahid Khan, Hafiz Muhammad Atif, Asim Shahzad, and Jamaluddin Mahar, “Computer-Aided Analysis of Oxino-bis-Pyrazolederivative as a Potential Breast Cancer Drug Based on DFT, Molecular Docking, and Pharmacokinetic Studies: Compared with the Standard Drug Tamoxifen”, IJBR, vol. 3, no. 6, pp. 535–537, Jun. 2025, doi: 10.70749/ijbr.v3i6.1724.